168 related articles for article (PubMed ID: 34694452)
21. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma.
Caturelli E; Bartolucci F; Biasini E; Vigliotti ML; Andriulli A; Siena DA; Attino V; Bisceglia M
Am J Gastroenterol; 2002 Feb; 97(2):397-405. PubMed ID: 11866279
[TBL] [Abstract][Full Text] [Related]
22. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.
Scharitzer M; Schima W; Schober E; Reimer P; Helmberger TK; Holzknecht N; Stadler A; Ba-Ssalamah A; Weber M; Wrba F
J Comput Assist Tomogr; 2005; 29(2):181-90. PubMed ID: 15772534
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma presenting as a tumour of the hilar and extrahepatic bile ducts.
Thomsen GH; Kruse A; Petersen A
Eur J Gastroenterol Hepatol; 1998 Sep; 10(9):803-4. PubMed ID: 9831278
[TBL] [Abstract][Full Text] [Related]
24. Comparison of pulsed and oscillating gradient diffusion-weighted MRI for characterizing hepatocellular nodules in liver cirrhosis: ex vivo study in a rat model.
Wagner M; Doblas S; Poté N; Lambert SA; Ronot M; Garteiser P; Paradis V; Vilgrain V; Van Beers BE
J Magn Reson Imaging; 2020 Apr; 51(4):1065-1074. PubMed ID: 31507025
[TBL] [Abstract][Full Text] [Related]
25. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
26. Differentiation of small (≤ 3 cm) hepatocellular carcinomas from benign nodules in cirrhotic liver: the added additive value of MRI-based radiomics analysis to LI-RADS version 2018 algorithm.
Zhong X; Guan T; Tang D; Li J; Lu B; Cui S; Tang H
BMC Gastroenterol; 2021 Apr; 21(1):155. PubMed ID: 33827440
[TBL] [Abstract][Full Text] [Related]
27. Maximum Value Measured by 2-D Shear Wave Elastography Helps in Differentiating Malignancy from Benign Focal Liver Lesions.
Tian WS; Lin MX; Zhou LY; Pan FS; Huang GL; Wang W; Lu MD; Xie XY
Ultrasound Med Biol; 2016 Sep; 42(9):2156-66. PubMed ID: 27283039
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.
Charlotte F; L'Herminé A; Martin N; Geleyn Y; Nollet M; Gaulard P; Zafrani ES
Am J Pathol; 1994 Mar; 144(3):460-5. PubMed ID: 8129031
[TBL] [Abstract][Full Text] [Related]
29. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
Teefey SA; Hildeboldt CC; Dehdashti F; Siegel BA; Peters MG; Heiken JP; Brown JJ; McFarland EG; Middleton WD; Balfe DM; Ritter JH
Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
[TBL] [Abstract][Full Text] [Related]
30. Primary intrahepatic small-cell carcinoma arising from combined hepatocellular and cholangiocarcinomas.
Khaw YL; Nolan N; Heaslip I; McCormick PA; Sheahan K
J Clin Oncol; 2011 Jul; 29(21):e630-3. PubMed ID: 21606429
[No Abstract] [Full Text] [Related]
31. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients.
Nagafuchi Y; Okamoto K; Shono M; Higure A; Todoroki H; Itoh H; Takeda S; Katumoto F; Toyoshima S
Hepatogastroenterology; 1998; 45(20):523-7. PubMed ID: 9638442
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
33. Significance of endothelium in the fine-needle aspiration biopsy diagnosis of hepatocellular carcinoma.
Pitman MB; Szyfelbein WM
Diagn Cytopathol; 1995 May; 12(3):208-14. PubMed ID: 7621715
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules ≤ 2 cm in cirrhotic patients.
Darnell A; Rimola J; Belmonte E; Ripoll E; Garcia-Criado Á; Caparroz C; Díaz-González Á; Vilana R; Reig M; Ayuso C; Bruix J; Forner A
Eur Radiol; 2021 Jul; 31(7):4794-4803. PubMed ID: 33409789
[TBL] [Abstract][Full Text] [Related]
35. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy.
Torzilli G; Minagawa M; Takayama T; Inoue K; Hui AM; Kubota K; Ohtomo K; Makuuchi M
Hepatology; 1999 Oct; 30(4):889-93. PubMed ID: 10498639
[TBL] [Abstract][Full Text] [Related]
36. Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
Sacks A; Peller PJ; Surasi DS; Chatburn L; Mercier G; Subramaniam RM
AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051
[TBL] [Abstract][Full Text] [Related]
37. [Overview: liver tumors].
Graziadei I
Wien Med Wochenschr; 2013 Mar; 163(5-6):109-12. PubMed ID: 23361850
[TBL] [Abstract][Full Text] [Related]
38. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma: stiffness value and ratio to discriminate malignant from benign focal liver lesions.
Lu Q; Ling W; Lu C; Li J; Ma L; Quan J; He D; Liu J; Yang J; Wen T; Wu H; Zhu H; Luo Y
Radiology; 2015 Jun; 275(3):880-8. PubMed ID: 25636031
[TBL] [Abstract][Full Text] [Related]
40. Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.
Jain R; Malhotra V; Kumar N; Sarin SK
Trop Gastroenterol; 1998; 19(3):100-1. PubMed ID: 9828706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
